MIT Cooks Up A Recipe To Make Startups Percolate

Take one creative scientist-turned-entrepreneur hawking a hot new technology. Sit him next to a venture capitalist hungry for investment opportunities. And, just to mix things up a bit, toss in a corporate executive on the prowl for a new product to bring to market. What have you got? All the ingredients for a potent dish of startup success, says John T. Preston, director of technology licensing for MIT Preston should know. A recent study identified 404 MIT alumni-founded companies in Massac

Written bySusan J. Dickinson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Take one creative scientist-turned-entrepreneur hawking a hot new technology. Sit him next to a venture capitalist hungry for investment opportunities. And, just to mix things up a bit, toss in a corporate executive on the prowl for a new product to bring to market. What have you got? All the ingredients for a potent dish of startup success, says John T. Preston, director of technology licensing for MIT

Preston should know. A recent study identified 404 MIT alumni-founded companies in Massachusetts.. Together, they employ more than 160,000 people and have annual revenues in excess of $27 billion. That’s one-fifth of the state’s gross product, notes Preston.

To keep the startup pot boiling, MIT hosted a Technology Transfer Conferences Inc. meeting last month designed to promote investments in—and partnering relationships with—young companies. Ten venture capital groups and 21 potential corporate partners showed up to watch 22 high-tech startups strut their stuff.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies